Vietnam Investment Review on MSN
Caliway submits CBL-514 for FDA Phase 2 weight management trial
Caliway Biopharmaceuticals (TWSE: 6919) today announced that it has completed the submission of an Investigational New Drug (IND) application to the U.S. FDA for a Phase 2 clinical study of its ...
20hon MSN
The whoppers of 2025
With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...
Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback